Free shipping on all orders over $ 500

NE 52-QQ57

Cat. No. M10634

All AbMole products are for research use only, cannot be used for human consumption.

NE 52-QQ57 Structure
Synonym:

NE52QQ57

Size Price Availability Quantity
5mg USD 200  USD200 In stock
10mg USD 300  USD300 In stock
25mg USD 600  USD600 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

NE 52-QQ57 is an orally available GPR4 antagonist with an IC50 of 70 nM. NE 52-QQ57 significantly inhibited the AGE-induced increased expression of several key inflammatory cytokines and signaling molecules, including tumor necrosis factor-α (TNF-α), interleukin (IL)-1β, IL-6, inducible nitric oxide synthase (iNOS), nitric oxide (NO), cyclooxygenase 2 (COX2), and prostaglandin E2 (PGE2). The GPR4 antagonist NE 52-QQ57 effectively blocked GPR4-mediated cAMP accumulation (IC50 26.8 nM in HEK293 cells). In HUVEC which natively express GPR4, physiological acidification (pH 7.4-7.0) resulted in a cAMP increase by ∼55% which was completely prevented by 1 μM NE 52-QQ57. The main extracellular organic acid, l-lactic acid (LL; 1-10 mM), suppressed pH dependent activation of GPR4 in HEK293 and HUVEC cells, suggesting allosteric negative modulation. In unanaesthetised mice and rats, NE 52-QQ57 (20 mg kg-1) reduced ventilatory response to 5 and 10% CO2. In anaesthetised rats, systemic administration of NE 52-QQ57 (up to 20 mg kg-1) had no effect on hemodynamics, cerebral blood flow and blood oxygen level dependent responses. Central administration of NE 52-QQ57 (1 mM) in vagotomised anaesthetised rats did not affect CO2-induced respiratory responses.

Chemical Information
Molecular Weight 416.52
Formula C24H28N6O
CAS Number 1401728-56-0
Solubility (25°C) DMSO ≥ 5 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Haochuan Liu, et al. Chem Res Toxicol. Antagonism of GPR4 with NE 52-QQ57 and the Suppression of AGE-Induced Degradation of Type II Collagen in Human Chondrocytes

[2] P S Hosford, et al. Neuropharmacology . CNS distribution, signalling properties and central effects of G-protein coupled receptor 4

[3] Juraj Velcicky, et al. J Med Chem . Development of Selective, Orally Active GPR4 Antagonists with Modulatory Effects on Nociception, Inflammation, and Angiogenesis

Related GPR/FFAR Products
GPR84 antagonist 8 

GPR84 antagonist 8 is a selective GPR84 antagonist.

ML191

ML-191 is an antagonist of GPR55.

CID1172084 

CID1172084 is a selective GPR55 agonist (EC50=0.16 μM).

ML 145 

ML 145 is a selective and competitive human GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM.

PSN 375963 hydrochloride 

PSN 375963 hydrochloride is a potent GPR119 agonist, with EC50s of 8.4 and 7.9 μM for human and mouse GPR119, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: NE 52-QQ57, NE52QQ57 supplier, GPR/FFAR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.